BONE DISEASE

Por Evangelos Terpos
Publicado em 2022-04-01

Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma

Por Despina Fotiou, Maria Gavriatopoulou, Evangelos Terpos, Meletios A. Dimopoulos
Publicado em 2022-05-01

The Emerging Role of Convalescent Plasma in the Treatment of COVID-19

Por Theodora Psaltopoulou, Theodoros N. Sergentanis, Vasiliki Pappa, Marianna Politou, Evangelos Terpos, Sotirios Tsiodras, George N. Pavlakis, Meletios A. Dimopoulos
Publicado em 2020-06-01

Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib

Por Panagiotis Efentakis, Hendrik Doerschmann, Claudius Witzler, Svenja Siemer, Panagiota-Efstathia Nikolaou, Efstathios Kastritis, Roland Stauber, Meletios Athanasios Dimopoulos, Philip Wenzel, Ioanna Andreadou, Evangelos Terpos
Publicado em 2020-07-01

Characterizing Kinetics and Avidity of SARS-CoV-2 Antibody Responses in COVID-19 Greek Patients

Por Stavroula Labropoulou, Niki Vassilaki, Raphaela S. Milona, Evangelos Terpos, Marianna Politou, Vasiliki Pappa, Maria Pagoni, Elisavet Grouzi, Meletios A. Dimopoulos, Andreas Mentis, Mary Emmanouil, Emmanouil Angelakis
Publicado em 2022-04-01

Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making

Por Sebastian Gonzalez-McQuire, Meletios-Athanassios Dimopoulos, Katja Weisel, Walter Bouwmeester, Roman Hájek, Marco Campioni, Craig Bennison, Weiwei Xu, Krystallia Pantiri, Marja Hensen, Evangelos Terpos, Stefan Knop
Publicado em 2019-01-01

Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome

Por Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Maria Roussou, Ioanna Dialoupi, Panagiotis Malandrakis, Foteini Theodorakakou, Efstathios Kastritis, Evangelos Terpos, Meletios-Athanasios Dimopoulos
Publicado em 2020-06-01

Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity

Por Tina Bagratuni, Dimitrios Patseas, Nefeli Mavrianou-Koutsoukou, Christine Ivy Liacos, Aimilia D. Sklirou, Pantelis Rousakis, Maria Gavriatopoulou, Evangelos Terpos, Ourania E. Tsitsilonis, Ioannis P. Trougakos, Efstathios Kastritis, Meletios A. Dimopoulos
Publicado em 2020-10-01

B03: SKELETAL-RELATED EVENTS AND ABNORMAL MRI PATTERN AT DIAGNOSIS ARE ASSOCIATED WITH INFERIOR OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

Por Evangelos Terpos, Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Vassilis Koutoulidis, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Tina Bagratuni, Maria Roussou, Lia A Moulopoulos, Meletios A Dimopoulos
Publicado em 2022-04-01

Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study

Por Konstantinos Anargyrou, Despina Fotiou, Theodoros P. Vassilakopoulos, Dimitrios Christoulas, Polyzois Makras, Maria Dimou, Ioannis Ntanasis-Stathopoulos, Stavroula Masouridou, Maria K. Angelopoulou, Athanasios Papatheodorou, Konstantinos Tsionos, Panayiotis Panayiotidis, Meletios A. Dimopoulos, Evangelos Terpos
Publicado em 2019-12-01

Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker

Por Anastasios I. Birmpilis, Antonios Paschalis, Apostolis Mourkakis, Panayiota Christodoulou, Ioannis V. Kostopoulos, Elina Antimissari, Georgia Terzoudi, Alexandros G. Georgakilas, Christina Armpilia, Panagiotis Papageorgis, Efstathios Kastritis, Evangelos Terpos, Meletios A. Dimopoulos, Hubert Kalbacher, Evangelia Livaniou, Maria-Ioanna Christodoulou, Ourania E. Tsitsilonis
Publicado em 2022-04-01